Interventional Study to Evaluate the Combination of Palbociclib + Sunitinib as a Treatment for Advanced Solid Tumors
Clinical trial NCT06940349 · RECRUITING
Trial details
- NCT number
- NCT06940349
- Sponsor
- Rabin Medical Center
- Status
- RECRUITING
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2021-10-21
- Primary completion
- 2026-01-01
- Enrollment
- 100
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.